Compounds > 2,2'-dihydroxy-3,3'-di-tert-butyl-5,5'-dimethoxydiphenyl
Page last updated: 2024-12-07

2,2'-dihydroxy-3,3'-di-tert-butyl-5,5'-dimethoxydiphenyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,2'-dihydroxy-3,3'-di-tert-butyl-5,5'-dimethoxydiphenyl: metabolite of butylated hydroxyanisole [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID119234
SCHEMBL ID240515
MeSH IDM0119398

Synonyms (42)

Synonym
3-tert-butyl-4-hydroxyanisole dimer
2,2'-dihydroxy-3,3'-di-tert-butyl-5,5'-dimethoxydiphenyl
ccris 3747
3,3'-bis(1,1-dimethylethyl)-5,5'-dimethoxy-(1,1'-biphenyl)-2,2'-diol
(1,1'-biphenyl)-2,2'-diol, 3,3'-bis(1,1-dimethylethyl)-5,5'-dimethoxy-
14078-41-2
3,3'-di-tert-butyl-5,5'-dimethoxybiphenyl-2,2'-diol
2-tert-butyl-6-(3-tert-butyl-2-hydroxy-5-methoxyphenyl)-4-methoxyphenol
s16m65880c ,
ec 604-200-4
unii-s16m65880c
5,5'-dimethoxy-3,3'-di-tert.-butyl-1,1'-biphenyl-2,2'-diol
AKOS016034719
3,3'-di-tert-butyl-5,5'-dimethoxy-2,2'-biphenyldiol
3,3'-di-tert-butyl-2,2'-dihydroxy-5,5'-dimethoxybiphenyl
2,2'-dihydroxy-3,3'-di-tert-butyl-5,5'-dimethoxy-1,1'-biphenyl
3,3'-di-tert-butyl-2,2'-dihydroxy-5,5'-dimethoxydiphenyl
6,6'-di(tert-butyl)-4,4'-dimethoxy-2,2'-biphenol
2,2'-dihydroxy-5,5'-dimethoxy-3,3'-di-tert-butylbiphenyl
3,3'-di-tert-butyl-2,2'-dihydroxy-5,5'-dimethoxy-1,1'-biphenyl
o,o'-biphenol, 6,6'-di-tert-butyl-4,4'-dimethoxy-
2,2'-biphenyldiol, 3,3'-di-tert-butyl-5,5'-dimethoxy-
SCHEMBL240515
3,3'-di-tert-butyl-5,5'-dimethoxy-[1,1'-biphenyl]-2,2'-diol
2,2'-dihydroxy-3,3'-di-t-butyl-5,5'-dimethyoxy-1,1'-biphenyl
3,3'-di-tert-butyl-5,5'-dimethoxy[1,1'-biphenyl]-2,2'-diol
2,2'-dihydroxy-3,3'-di-t-butyl-5,5'-dimethoxy-1,1'-biphenyl
3,3'-di-tert-butyl-5,5'-dimethoxy-[1,1-biphenyl]-2,2'-diol
CBYWHFTZNVZQHV-UHFFFAOYSA-N ,
mfcd01112111
2,2'-dihydroxy-5,5'-dimethoxy-3,3'-di-tert-butyl-biphenyl
F16139
DTXSID00930919
STL195335
Q27288431
A927919
WS-01628
2,2/'-dihydroxy-3,3/'-di-tert-butyl-5,5/'-dimethoxydiphenyl
CS-0217412
EN300-7425725
3,3 inverted exclamation mark -di-tert-butyl-5,5 inverted exclamation mark -dimethoxy-[1,1 inverted exclamation mark -biphenyl]-2,2 inverted exclamation mark -diol
SY333413
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.31 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.25 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
propyl gallate
Propyl Gallate: Antioxidant for foods, fats, oils, ethers, emulsions, waxes, and transformer oils.		1.9910trihydroxybenzoic acid
topanol 354
Topanol 354: structure		210methoxybenzenes;
phenols
morphine
Meconium: The thick green-to-black mucilaginous material found in the intestines of a full-term fetus. It consists of secretions of the INTESTINAL GLANDS; BILE PIGMENTS; FATTY ACIDS; AMNIOTIC FLUID; and intrauterine debris. It constitutes the first stools passed by a newborn.		1.9610morphinane alkaloid;
organic heteropentacyclic compound;
tertiary amino compound		anaesthetic;
drug allergen;
environmental contaminant;
geroprotector;
mu-opioid receptor agonist;
opioid analgesic;
plant metabolite;
vasodilator agent;
xenobiotic
mocetinostat
mocetinostat: undergoing phase II clinical trials for treatment of cancer. mocetinostat : A benzamide obtained by formal condensation of the carboxy group of 4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzoic acid with one of the amino groups of benzene-1,2-diamine. It is an orally active and isotype-selective HDAC inhibitor which exhibits antitumour activity (IC50 = 0.15, 0.29, 1.66 and 0.59 muM for HDAC1, HDAC2, HDAC3 and HDAC11).		1.9710aminopyrimidine;
benzamides;
pyridines;
secondary amino compound;
secondary carboxamide;
substituted aniline		antineoplastic agent;
apoptosis inducer;
autophagy inducer;
cardioprotective agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
hepatotoxic agent
ConditionIndicatedRelationship StrengthStudiesTrials
Sensitivity and Specificity
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)		01.9910